Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

U.S. stock futures were little changed on Thursday night after the major averages slid following a lackluster earnings ...

The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S.

Bev battled health issues, including sleep apnoea and depression, and believed she was half-a-stone away from being ...

Read full article: How to score Valentine's chocolates from this Broadway chocolatier From chocolate lollipops to boxes and hot chocolate, Mozna Chocolate & Coffee Co. may be your new go-to for ...

“We are pleased the FDA has declared that supply of the only real, FDA-approved semaglutide medicines is resolved, affirming ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

Eli Lilly's tirzepatide has been shown to significantly cut cardiovascular risks in patients with obesity and a form of heart failure with few treatment options, in another big win for the GLP-1 ...

Ro shares information about how eggs can support weight loss efforts, and the best way to prepare them to meet health goals.

Eli Lilly’s diabetes and obesity therapy tirzepatide could find a use as a treatment for obstructive sleep apnoea (OSA) after hitting the mark in a pair of phase 3 trials. OSA is a prevalent ...

Regeneron (NASDAQ: REGN) is testing its drug, trevogrumab, along with Wegovy and another treatment, garetosmab, in a ...